In Vitro Activity of Telithromycin, Quinupristin/Dalfopristin, Linezolid and Comparator Antimicrobial Agents Against Staphylococcus aureus Clinical Isolates

REFERENCES

• Rowe F, Vargas Superti S, Machado Scheibe R, Comes Dias C. Agar diffusion, agar dilution, Eteste, and agar screen-ing test in the detection of methicillin resistance in staphylo-cocci. Diag Microbiol Infect Dis 2002; 43: 45–48.
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, the SENTRY Participants Group. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates col-lected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Programme, 1997-1999. Clin Infect Dis 2001; 32 (Suppl 2): S114-132.
   Google Scholar
• Ballow CH, Jones RN, Biedenbach DJ, the North American ZAPS Research Group. A multicenter evaluation of linezolid antimicrobial activity in North America. Diag Microbiol Infec Dis 2002; 43: 75–83.
   PubMed Web of Science ®Google Scholar
• Martineau F, Picard FJ, Lansac N, Mênard C, Roy PH, Ouellette M, Bergeron MG. Correlation between the resis-tance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 2000; 44: 231–238.
   PubMed Web of Science ®Google Scholar
• Lim JA, Kwon AR, Kim SK, Chong Y, Lee K, Choi EC. Prevalence of resistance to macrolide, lincosamide and strep-togramin antibiotics in Gram-positive cocci isolated in a Korean hospital. J Antimicrob Chemother 2002; 49: 489–495.
   PubMed Web of Science ®Google Scholar
• Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J. Distribution of genes encoding resis-tance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother 1999; 43: 1062–1066.
   PubMed Web of Science ®Google Scholar
• Schmitz FJ, Sadurski R, Kray A, et al. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother 2000; 45: 891–894.
   PubMed Web of Science ®Google Scholar
• Leclercq R. Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycin. J Antimicrob Chemother 2001; 48: Topic Ti, 9-23.
   Google Scholar
• Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppálá H. Nomenclature for macrolide and macrolide-lin-cosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43: 2823–2830.
   PubMed Web of Science ®Google Scholar
• Schmitz FJ, Verhoef J, Fluit AC, The SENTRY Participants Group. Prevalence of resistance to MLS antibi-otics in 20 European university hospitals participating in the European SENTRY surveillance programme. J Antimicrob Chemother 1999; 43: 783–792.
   Google Scholar
• Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34: 482–492.
   PubMed Web of Science ®Google Scholar
• Araj GF, Talhouk RS, Simaan CJ, Maasad MJ. Discrepancies between mecA PCR and conventional tests used for detection of methicillin resistant Staphylococcus aureus. Int J Antimicrob Agents 1999; 11: 47–52.
   PubMed Web of Science ®Google Scholar
• Tan TY. A comparison of PCR detection of mecA with two standard methods of oxacillin disk susceptibility testing for coagulase-negative staphylococci. J Med Microbiol 2002; 51: 83–85.
   PubMed Web of Science ®Google Scholar
• Werner G, Cuny C, Schmitz FJ, Witte W. Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides. J Clin Microbiol 2001; 39: 3586–3590.
   PubMed Web of Science ®Google Scholar
• Del' Alamo L, Cereda RF, Tosin I, Miranda EA, Sader HS. Antimicrobial susceptibility of coagulase-negative staphylo-cocci and characterization of isolates with reduced susceptibili-ty to glycopeptides. Diagn Microbiol Infect Dis 1999; 34: 185–191.
   PubMed Web of Science ®Google Scholar
• John MA, Pletch C, Hussain Z. In vitro activity of quin-upristin/dalfopristin, linezolid, telithromycin and comparator antimicrobial agents against 13 species of coagulase-negative staphylococci. J Antimicrob Chemother 2002; 50: 933–938.
   PubMed Web of Science ®Google Scholar
• Johnson AP, Warner M, Livermore DM. Activity of linezolid against multi-resistant Gram-positive bacteria from diverse hospitals in the United Kingdom. J Antimicrob Chemother 2000; 45: 225–230.
   PubMed Web of Science ®Google Scholar
• Seppálá H, Nissinen A, Yu Q, Huovinen P. Three dif-ferent phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993; 32: 885–891.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; Fourteenth Informational Supplement M100-514 (M2). NCCLS, Wayne, PA, 2004.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; Fourteenth International Supplement M100-514 (M7). NCCLS, Wayne, PA, 2004.
   Google Scholar
• Comité de l'Antibiogramme de la Societê Française de Microbiologie Report 2003. Members of the SFM Antibiogram Committee. Int J Antimicrob Agents 2003; 21: 364–391.
   Google Scholar
• Hamilton-Miller JMT, Shah S. Patterns of phenotypic resistance to the macrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci. J Antimicrob Chemother 2000; 46: 941–949.
   PubMed Web of Science ®Google Scholar
• Muñoz Bellido JL, Gutiérrez Zufiaurre MN, Sánchez Hernández FJ, Yagtie Guirao G, Segovia Hernández M, Garcia-Rodriguez JA. In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoro-quinolone-resistant methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2002; 20: 61–64.
   PubMed Web of Science ®Google Scholar
• Schmitz FJ, Petridou J, Milatovic D, Verhoef J, Fluit AC, Schwarz S. In vitro activity of new ketolides against macrolide-susceptible and —resistant Staphylococcus aureus isolates with defined resistance gene status. J Antimicrob Chemother 2002; 49: 573–584.
   PubMed Web of Science ®Google Scholar
• Shortridge VD, Thong P, Cao Z, Beyer JM, Almer LS, Ramer NC, Doktor S.Z, Flamm RK. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-sus-ceptible and —resistant streptococci and staphylococci. Antimicrob Agents Chemother 2002; 46: 783–786.
   Google Scholar
• Fuchs PC, Barry AL, Brown SD. Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: din-damycin susceptibility as a surrogate indicator. Antimicrob Agents Chemother 2000; 44: 2880–2882.
   PubMed Web of Science ®Google Scholar
• Noskin GA, Siddiqui F, Stosor V, Hacek D, Peterson LR. In vitro activities of linezolid against important Gram-posi-tive bacterial pathogens including vancomycin-resistant entero-cocci. Antimicrob Agents Chemother 1999; 43: 2059–2062.
   PubMed Web of Science ®Google Scholar
• Fluit AC, Schmitz FJ, Verhoef J, European SENTRY Participants. Multi-resistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens. Int J Antimicrob Agents 2001; 18: 147–160.
   PubMed Web of Science ®Google Scholar
• Viudes A, Pêrez-Bellês C, Tall6n P, Cano J, Petialver MC, Pemán J, Gobernado M. Susceptibility of Staphylococcus aureus isolated from blood to 11 antimicro-bial agents and a review of the literature. Rev Esp Quimioterap 2002; 15 (2): 158-168.
   Google Scholar
• Berger-Bachi B. Resistance mechanisms of Gram-posi-tive bacteria. Int J Med Microbiol 2002; 292: 27–35.
   PubMed Web of Science ®Google Scholar
• Skurray RA, Firth N. Molecular evolution of multiply-antibiotic-resistant staphylococci. Ciba Found Symp. 1997; 207: 167–83.
   PubMedGoogle Scholar